John M. Gregory

Chairman of the Board and Chief Executive Officer

Serving as Chairman and CEO for Gregory Pharmaceutical Holdings,, John M. Gregory is a pioneer in specialty pharmaceuticals. In 2002, John received the Ernst & Young Entrepreneur of the Year award, honored as the winner in the Health Sciences category. After graduating from the University of Maryland with a degree in pharmacy, John and his wife, Joan, moved to Bastian, Virginia, where he opened the town’s first retail pharmacy. Seeing an opportunity to expand, in 1984 John co-founded General Injectables and Vaccines (GIV), a company that supplied injectables and vaccine products directly to physicians’ offices. As president and CEO, John turned GIV into a successful enterprise with 550 employees and annual revenues exceeding $150 million annually. With a small initial investment in their pockets and a lot of debt on their shoulders, John and his brothers purchased a pharmaceutical manufacturing facility in Bristol, Tennessee, in 1993. Under John’s leadership as chairman and CEO from 1993-2001, King Pharmaceuticals grew from a 90-employee family business to an S&P 500 Index company on the New York Stock Exchange with revenues exceeding $1 billion.

James E. Gregory

President and Chief Operating Officer

James E. Gregory served as the President and Chief Operating Officer of UPM from 2004 to 2007. After retiring in January, 2008, he was reappointed to this position in October, 2009. Gregory previously worked for King Pharmaceuticals from 1995 to 2000 as Executive Vice President and General Manager of King’s Bristol, Tennessee manufacturing facility. He served in various consulting capacities at King from 2000 to 2003 and served on the Board of Directors in 2002 and 2003. Gregory served from 1982 to 1995 as a senior administrator in the court systems of Phoenix, Arizona and Washington, D.C. He was deputy executive officer in charge of business operations of the District of Columbia Court System from 1990 to 1995. Gregory has a B. A. from the University of Maryland and a masters in public administration from American University.

Greg Tebeau

Chief Financial Officer

Gregory J. Tebeau is responsible for the accurate development and implementation of all financial reporting, policies, and procedures. He protects the integrity of the company’s assets by participating in strategic development and evaluating deal processes.

Prior to joining Gregory Pharmaceutical Holdings, Greg was executive vice president of finance with King Pharmaceuticals, Inc., for six years. He was responsible for all daily accounting operations and internal financial reporting of the S&P 500 company. In addition, he had oversight of all tax- compliance filings and audits with federal, state, and local government agencies.

Greg’s previous experience includes eleven years in public accounting, which led to his position as vice president of taxation for a Washington, D.C., firm specializing in non-profit entities. While in the nation’s capitol, Greg also worked as a senior accountant for Robert Philipson & Company. Former positions include comptroller for a medical-device consulting firm, and treasurer for a government relations and management firm. Greg received his BS in accounting from the University of Maryland.

Susan K. Gregory


Susan Gregory currently serves as President & COO of NFI Consumer Products, a subsidiary of Gregory Pharmaceutical Holdings.

Involved in the family investment company, SJ Strategic Investments, since graduating from college, Susan acts as a sounding board to ensure that all decisions and investments are in keeping with the company’s values and goals. As CIO of SJ Strategic Investments LLC, Susan manages the company’s current portfolio of investments, developing and executing investment strategies as she actively monitors asset growth and profitability targets. Whenever necessary, Susan is a spokesperson for her father, SJ Strategic Investments Managing Partner John M. Gregory.

Susan is on the boards of UPM Pharmaceuticals, Inc., a Baltimore-based, independent drug development and contract manufacturer and Serving Orphans Worldwide, a non-profit organization based in Bristol, Tennessee that helps orphanages around the world.  She also serves as a board advisory member for Kingsway Charities Inc., a faith-based charitable organization in Bristol, Virginia that delivers medical supplies and other health care related products to the needy in foreign countries.

She holds a BS in Business Administration from the University of Tennessee and a MS in Library and information Science from Drexel University.

James M. Gregory

Corporate Secretary and Chief Legal Officer

James M. Gregory directs various aspects of the company’s legal issues, provides strategic advice, and supervises every deal and contract. Before joining Gregory Pharmaceutical Holdings, he served as a Legal Intern at the Sullivan County Tennessee District Attorney’s Office researching criminal law questions, writing informational memos and preparing trial exhibits. He is a board member of the Lazarus Foundation, a non-profit that helps Christian charities with their financial needs and Regent University. He also serves on the board of UPM Pharmaceuticals, Inc., a Bristol, TN – based pharmaceutical contract research and manufacturing company. A member of the Tennessee Bar, Gregory received his Doctor of Jurisprudence from Regent University School of Law in Virginia Beach, Virginia. He has a BA in Political Science from King College in Bristol, Tennessee.